News
Palantir Technologies (PLTR) reported better-than-expected first quarter results and raised its full-year guidance. The enterprise technology firm now expects f ...
Shares of Trade Desk (TTD) extended its Thursday's post-market rally after the adtech firm guided ahead of the expectations ...
Rapport Therapeutics, Inc. RAP-219 Phase 2a trial in patients with refractory focal epilepsy remains on track with topline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results